[Participation in the global study. Activities and issues from the bedside].
Global study is becoming popular in the field of the anti-cancer drug development in Japan as well as in the US and European countries. There are many issues to be solved around the bedside and equipping the infrastructure is most important. Early drug development is also important,and we are maintaining the quality and speed in the phase I studies.
Yamamoto
Noboru
N
Division of Internal Medicine & Thoracic Oncology, National Cancer Center Hospital.
D000970:Antineoplastic Agents; D017321:Clinical Trials, Phase I as Topic / Q000379:methods / Q000706:statistics & numerical data; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D007391:International Cooperation; D017387:Investigational New Drug Application; D008495:Medical Oncology
D000970:Antineoplastic Agents